Navigating Your Journey: Can You Take Wegovy When Trying to Get Pregnant?

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has transformed weight management for millions, but women planning pregnancy often face tough questions about continuing treatment. Current evidence suggests stopping semaglutide before conception is the safest approach, though individual circumstances vary significantly. PlexusDx helps patients navigate this decision with personalized guidance aligned with reproductive health goals.

What You Need to Know About Semaglutide and Pregnancy Planning

Semaglutide is a GLP-1 receptor agonist designed to reduce appetite and improve blood sugar control, leading to gradual weight loss over months. While clinical trials have not identified direct birth defects from semaglutide exposure, the medication was not extensively studied in pregnant populations, creating uncertainty. Manufacturers recommend discontinuing semaglutide at least two months before attempting conception to allow the medication to clear your system completely.

The decision to stop semaglutide during fertility planning involves weighing weight loss momentum against reproductive safety. Many reproductive health specialists recommend pausing GLP-1 therapy when actively trying to conceive, shifting focus to sustainable nutrition and exercise habits. Your timeline matters: if you've been on semaglutide for several months and achieved significant weight loss, stopping medication may not reverse progress if healthy behaviors remain in place.

Semaglutide Clearance and Conception Timing

Semaglutide injections remain in your bloodstream for approximately one week after each dose, which is why a two-month washout period provides adequate time for complete elimination. Most reproductive endocrinologists suggest stopping injections at least 60 days before your planned conception attempt, though some recommend starting cessation when you first decide to pursue pregnancy. This buffer ensures the medication is completely absent before implantation occurs.

If you've been taking semaglutide consistently, your body will continue benefiting from the lifestyle changes and reduced appetite patterns you've developed, even after stopping injections. Many patients find that the weight loss achieved during semaglutide therapy remains stable afterward because they've built sustainable eating habits. Discussing your specific timeline with both your weight management provider and obstetrician helps coordinate safe transitions.

Alternative Weight Management Strategies During Fertility Planning

During the months you're not taking semaglutide, maintaining weight loss and metabolic health becomes your priority through evidence-based nutrition and physical activity. A registered dietitian can help you develop a conception-focused meal plan that supports fertility while preventing weight regain after stopping medication. Regular moderate exercise, adequate protein intake, and stress management all support both reproductive health and sustained weight control.

Some patients explore whether resuming semaglutide after pregnancy is possible, particularly if breastfeeding plans change. If you're planning to bottle-feed, your healthcare provider may recommend restarting semaglutide once you're no longer pregnant or nursing, allowing you to resume personalized weight management therapy. PlexusDx offers flexible dosing options that can accommodate life transitions, with prices that remain flat regardless of dose adjustments—your dose may need to go up, but your price won't.

Personalized Pregnancy Planning With PlexusDx Genetic Insights

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

If you're using PlexusDx Compounded Semaglutide Injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan), your prescription comes from a licensed 503A compounding pharmacy with no insurance required—making it easy to pause and resume therapy as your reproductive timeline evolves. The Precision Peptide Genetic Test ($298) provides a personalized roadmap of which peptide-driven pathways drive your weight patterns, helping you optimize non-medication strategies during your fertility window. Whether you pause therapy or adjust your approach, PlexusDx supports continuity across major life decisions.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is it safe to take semaglutide while trying to get pregnant?

Current evidence does not show semaglutide causes birth defects, but manufacturers recommend stopping the medication at least two months before attempting conception since it wasn't extensively studied in pregnancy. Pausing treatment allows complete drug clearance and reduces uncertainty during early pregnancy development. Your reproductive health provider can discuss individual risk-benefit factors specific to your situation.

How long does semaglutide stay in your system when trying to conceive?

Semaglutide is cleared from your bloodstream approximately seven days after each injection, but manufacturers recommend a full two-month washout period before conception attempts to ensure complete elimination. This extended timeline accounts for individual metabolic variation and provides a safety buffer before pregnancy occurs. Stopping injections two months ahead gives your body ample time to process all remaining medication.

Will I regain weight if I stop semaglutide to get pregnant?

Weight regain depends on whether you maintain the nutrition and activity habits you developed during semaglutide therapy. Many patients preserve most weight loss after stopping because sustainable eating patterns remain in place. Working with a dietitian and exercise specialist during your fertility window helps protect your progress while you're off medication.

Can I restart semaglutide after pregnancy if I'm not breastfeeding?

Yes, many patients resume GLP-1 therapy postpartum after consultation with their obstetrician, especially if bottle-feeding eliminates medication transfer concerns. PlexusDx supports flexible therapy pauses and restarts without membership fees or insurance requirements, so you can adjust your treatment plan around major life events. Discuss timing with your healthcare provider, but resuming personalized semaglutide therapy remains an option after your reproductive window closes.

How does PlexusDx's Precision Peptide Genetic Test help with pregnancy planning and weight management?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (MC4R (rs17782313)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy Providers That Take Fsa Plexusdx
• Ro Wegovy
• Mochi Wegovy
• Noom Wegovy

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.